Microcompetition vs. New Definition of Autism; Good vs. Evil

Share Article

CBCD Says: Don’t discriminate against autistic kids. Fund the research to save them and protect future generations.

In January, an expert panel assigned by the American Psychiatric Association put forward a proposition to change the definition of Autism (ASD). [1] These changes will exclude many children from an Autism diagnosis. The Center for the Biology of Chronic Disease (CBCD) charges that these changes will cause serious harm to these children and to their families.

What is the real motivation behind a change in definitions? Is it financial? Who benefits from a change in definition? Since they will no longer have to provide services and/or insurance coverage, various state programs as well as health insurance companies, are just some organizations the CBCD believes will obviously benefit from the exclusion of large numbers of children from an Autism diagnosis.

According to the New York Times, “many experts have privately contended that the vagueness of the current criteria for Autism and related disorders like Asperger syndrome was contributing to the increase in the rate of diagnoses — which has ballooned to one child in 100, according to some estimates.” [2]

However, the CBCD asserts that a “too broad” definition of Autism does not lessen the fact that there are, without a doubt, more adults and children experiencing mental, emotional, and behavioral disabilities within the Autism spectrum than at any other time in history.

The CBCD’s Mike Davis said “I hate to see kids suffering. It doesn’t really matter if they have ‘light symptoms’ or are completely disabled. These kids and their families shouldn’t have to suffer because a bunch of psychiatrists feel they need to change definitions in order to ‘be more accurate.’ What’s ‘accurate’ anyway? It’s obvious that even kids that are only lightly affected by Autism have something going on that’s not normal. I think it’s entirely possible that this is more about financial interests than it is about the health of these kids or the needs of physicians to make better, more accurate, diagnoses.”

Moreover, the CBCD cautions that the new definition may falsely lower the numbers of those diagnosed with Autism…while the unknown factors that cause the range of disabilities in the Autism spectrum will continue to cause neural development problems.

Instead of a change in guidelines, the CBCD proposes that those who no longer wish to “foot the bill” for large numbers of Autistic children who are only mildly affected by the disorder, set up a fund for the investigation of the underlying cause of the illness.

As can be discerned from history, if medical professionals can learn the origin of the illness, then working toward a cure as a society becomes easier. Think of smallpox! It’s gone, and horrible suffering is no more. If scientists know the cause, they can prevent the disease, and treat the afflicted.

In terms of those already suffering, if a cure can be found, hundreds of thousands of people will be saved and expenses eliminated. Such an occurrence is worthy and honorable. When a cure is found, leaders in politics and business will secure their place in history.

How can leaders begin?

Allocate funds for researching the relationship between Microcompetition and Autism.

This relationship is described in Dr. Hanan Polansky’s “Purple Book” entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” and has been available as a free public access download from the CBCD website since 2003.

In fact, over 5,000 scientists around the world have read the book, including some at the NIH such as Dr. Sivasubramanian Baskar, PhD, who said, "At first, I wish to congratulate Dr. Hanan Polansky for his scientific bravery to take such a unique, novel approach to further stimulate our understanding of the origin and establishment of chronic diseases. The philosophy underscored is an excellent one ... The amazing correlation between theoretical predictions and observed in vivo effects seem to bring us a step closer to a deeper understanding of such complex biologic processes."

However, to date, no governmental or private interests have funded any serious studies regarding the potential relationship between Autism and Microcompetition.

The CBCD would like to see this change. The center believes state governments and health insurance companies are in a position to set up such funds in order to conduct these compelling studies and have the necessary motivation as well as resources to make such studies possible.

Don’t discriminate against autistic kids. Fund the research to save them and protect future generations.

The CBCD invites family doctors, pediatricians, scientists, the media, and the public to contact us on this issue.

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with Dr. Polansky, please visit http://www.cbcd.net or call 585-250-9999.

References:

[1] [2 http://www.nytimes.com/2012/01/20/health/research/new-autism-definition-would-exclude-many-study-suggests.html?pagewanted=all

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John S. Boyd, PhD
CENTER FOR THE BIOLOGY OF CHRONIC DISEASE
(585) 250-9999
Email >
Visit website